Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.

MLA

Scovell, Jason M., et al. “Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.” JAMA Oncology, vol. 6, no. 8, Aug. 2020, pp. 1297–99. EBSCOhost, https://doi.org/10.1001/jamaoncol.2020.1641.

APA

Scovell, J. M., Benz, K., Samarska, I., Kohn, T. P., Hooper, J. E., Matoso, A., & Herati, A. S. (2020). Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma. JAMA Oncology, 6(8), 1297–1299. https://doi.org/10.1001/jamaoncol.2020.1641

Chicago

Scovell, Jason M, Karl Benz, Iryna Samarska, Taylor P Kohn, Jody E Hooper, Andres Matoso, and Amin S Herati. 2020. “Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma.” JAMA Oncology 6 (8): 1297–99. doi:10.1001/jamaoncol.2020.1641.